End-of-day quote
Other stock markets
|
||
- USD | - |
|
14/05 | Earnings Flash (BSEM) BIOSTEM TECHNOLOGIES Reports Q1 Revenue $41.9M | MT |
2023 | NovaBay to Commercialize BioStem's Amniotic Tissue Allograft | MT |
Managers | Title | Age | Since |
---|---|---|---|
Andrew van Vurst
FOU | Founder | - | 07/06/07 |
Chief Executive Officer | - | 07/06/07 | |
Director of Finance/CFO | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thomas Dugan
CHM | Chairman | 66 | 13/12 |
Patrick Daly
BRD | Director/Board Member | - | 19/12 |
Chief Executive Officer | - | 07/06/07 |
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 115B | |
+22.18% | 26.64B | |
-21.81% | 19.91B | |
-16.89% | 16.32B | |
-18.81% | 15.49B | |
-44.74% | 15.52B | |
+62.72% | 14.83B | |
+3.09% | 13.67B |
- Stock Market
- Equities
- Stock